Veraxa Biotech Ag earnings were -$82.2M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest VRXA earnings report on Mar 31, 2026 announced Q1 2026 earnings of $180.5k, down 100.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, VRXA reported annual earnings of -$84.3M, with 169.8% growth.
What were Veraxa Biotech Ag's earnings last quarter?
Veraxa Biotech Ag (NASDAQ: VRXA) reported Q1 2026 earnings per share (EPS) of $0.01, up 91.23% year over year. Total VRXA earnings for the quarter were $180.50 thousand. In the same quarter last year, Veraxa Biotech Ag's earnings per share (EPS) was $0.11.
As of the last Veraxa Biotech Ag earnings report, Veraxa Biotech Ag is currently profitable. Veraxa Biotech Ag's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $6.74 million, a 123.69% decrease year over year.
What was VRXA's earnings growth in the past year?
As of Veraxa Biotech Ag's earnings date in Q3 2026, Veraxa Biotech Ag's earnings has grown year over year. VRXA earnings in the past year totalled -$82.24 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.